Our Team: Commercialization
Peter O'Neill Director, Commercialization
Prior to joining CCI, Mr. O'Neill was Deputy Director of Battelle's Great Lakes Industrial Technology Center, where he facilitated licenses and other technology transfer partnerships with the NASA Glenn Research Center. Previously, he worked as a process engineer for a number of investment casting companies... Continue Reading
Kaleigh Gallagher Innovations Analyst
As a member of the Commercialization team, Kaleigh is the initial point of contact for Cleveland Clinic inventors who are considering the commercial potential of their inventions. In her current role, she advises inventors on the commercialization process and... Continue Reading
Grant Hoffman Innovations Officer
Grant's areas of focus within the licensing team are the Biomedical Engineering department and the Glickman Urological and Kidney Institute. He previously held positions within research and product development at Cook Medical... Continue Reading
Neema Mayhugh Director, Commercial Affairs, Cole Eye Institute
Dr. Mayhugh's current focus is on technology commercialization in the ophthalmic therapeutic area. She joins CCI from Pfizer, Inc., where she was responsible for worldwide market analytics in age-related macular degeneration. Her previous experience also includes strategic consulting in the biotech, pharmaceutical... Continue Reading
Doug Meislahn Commercialization Analyst
Doug is a registered patent agent whose primary role at CCI is to serve as the initial point of contact for researchers and physicians who are considering the commercial prospects of their inventions. In this role, he advises inventors on their options, tracks incoming disclosures, and assembles background information... Continue Reading
Jason Ospina Innovations Associate
Dr. Ospina is a member of our licensing team and primarily focuses on the evaluation, marketing and commercialization of life science disclosures. Prior to joining CCI, Jason was a post-doctoral fellow at Cleveland Clinic's Lerner Research Institute. His research at Lerner centered on the delineation of mechanisms... Continue Reading
Marcie Reilly Commercialization Officer
As a member of the licensing team, Marcie's primary focus is on the evaluation, marketing and commercialization of disclosures related to medical device technologies. Prior to joining CCI, Marcie held several product development positions at Kensey Nash Corporation in the fields of interventional cardiology.... Continue Reading
Nisha Vagadia Innovations Officer
As a member of the commercialization team, Nisha's primary focus is on the evaluation, marketing and commercialization of disclosures in collaboration with several institutes including the Miller Family Heart & Vascular Institute, the Digestive Disease Institute, Endocrinology and Metabolism Institute...Continue Reading